FDA's Integrated Food Safety System Training Delivery and Development

The Food and Drug Administration (FDA), a key agency within the U.S. Department of Health and Human Services, has forecasted a cooperative agreement opportunity titled “FDA's Integrated Food Safety System Training Delivery and Development” (Opportunity Number: FOR-FD-25-016). This initiative aligns with the FDA’s mission to promote public health through the regulation and supervision of food safety. The grant supports the continued development of a national Integrated Food Safety System (IFSS), aiming to foster collaboration across federal, state, and local food safety entities through standardized training and communication. The primary objective of this funding opportunity is to enhance the delivery and development of training programs that support the IFSS model. The system is designed to unify diverse stakeholders in food safety to achieve seamless information sharing, consistent regulatory practices, and timely interventions. Training initiatives under this program are intended to strengthen the knowledge base and skill sets of food safety professionals, ensuring a more coordinated response to food safety threats nationwide. The funding mechanism for this opportunity is a cooperative agreement, indicating that the FDA will play a substantial role in overseeing and guiding the project activities of the selected recipients. While the total amount of funding available, award ceiling, and award floor amounts have not been disclosed at the forecast stage, the FDA expects to make approximately four awards under this opportunity. The grant is listed under Assistance Listing Number 93.103, which corresponds to FDA Research programs. Eligibility for this grant is highly restricted. Only current recipients under the prior funding opportunity RFA-FD-20-024 are eligible to apply. This makes the grant an exclusive continuation opportunity, not open to new applicants. As a result, only organizations with existing FDA-supported infrastructure in IFSS training are positioned to submit proposals. The opportunity is currently in a forecasted status, with a forecast date and last update on July 21, 2025. Estimated dates for the application posting, submission deadlines, award notifications, and project start have not yet been released. Since this is a forecasted opportunity, interested and eligible recipients should monitor Grants.gov and FDA announcements for updates on key dates and submission instructions. Questions regarding this funding opportunity should be directed to Patrick Johnson, the designated Grants Management Specialist for the FDA. He can be reached via email at patrick.johnson@fda.hhs.gov. Because this is a continuation opportunity limited to existing awardees, no broader application resources, questions, or guidance materials are publicly available at this time. Applicants are advised to refer to the original RFA-FD-20-024 documentation and to prepare for a formal announcement of full application instructions.